| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |